2. Rheumatology Clinic, 401 General Military Hospital of Athens, Athens, Greece
3. Paediatric Clinic, General University Hospital of Alexandroupolis, Alexandroupolis, Greece
ChristinaSpanopoulou
, Dimitrios Kassimos, Dimitrios CassimosVolume 31, Issue 3 - Supplement 2, September 2020
Sign in to download the Issue in PDF format.
661205880
Mediterr J Rheumatol 2020;31(Suppl 2):304-5
Article Links
Potential Role of Anti-Complement Agents in the Treatment of COVID-19-Related ARDS
Authors Information
1. Department of Internal Medicine, General Hospital of Amaliada, Amaliada, Greece
2. Rheumatology Clinic, 401 General Military Hospital of Athens, Athens, Greece
3. Paediatric Clinic, General University Hospital of Alexandroupolis, Alexandroupolis, Greece
ChristinaSpanopoulou, Dimitrios Kassimos, Dimitrios Cassimos
2. Rheumatology Clinic, 401 General Military Hospital of Athens, Athens, Greece
3. Paediatric Clinic, General University Hospital of Alexandroupolis, Alexandroupolis, Greece
ChristinaSpanopoulou
, Dimitrios Kassimos, Dimitrios CassimosAbstract
This article has no abstract.https://doi.org/10.31138/mjr.31.3.304
This work is licensed under a Creative Commons Attribution 4.0 International License (CC-BY). 
©Spanopoulou C, Kassimos D, Cassimos D.
Article Submitted: 30 Apr 2020; Article Accepted: 5 May 2020; Available Online: 8 Sep 2020
